Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences to Participate in 31st Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 20, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that at 1:30 PM PT / 4:30 PM ET on Wednesday, January 9, 2013, Mr. Peter Arduini, President and Chief Executive Officer of Integra, will present at the 31st Annual J.P.
View HTML
Toggle Summary Integra LifeSciences to Participate in the Oppenheimer 23rd Annual Healthcare Conference
PLAINSBORO, N.J., Dec. 3, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that at 10:00 AM ET on Wednesday, December 12, 2012, Mr. Jack Henneman, Chief Financial Officer of Integra, will present at the Oppenheimer 23rd Annual Healthcare Conference in
View HTML
Toggle Summary Integra LifeSciences LED Headlight System Receives Top Recognition in Surgical Products Magazine
PLAINSBORO, N.J., Nov. 29, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Surgical Products magazine has awarded Integra's LED Headlight System 1 st place in the "Capital Equipment" category of their 2012 "Excellence in Surgical Products
View HTML
Toggle Summary Integra LifeSciences is Honored as One of New Jersey's 2012 Fifty Fastest Growing Companies for Fourth Year in a Row
PLAINSBORO, N.J., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it was honored for the fourth year in a row as one of New Jersey's Fifty Fastest Growing Companies by NJBIZ, one of New Jersey's leading statewide business newspapers.
View HTML
Toggle Summary Integra LifeSciences Receives Warning Letter in Andover, England Manufacturing Facility
PLAINSBORO, N.J., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that on November 5, 2012 it received a warning letter from the United States Food and Drug Administration (FDA) related to quality systems issues at its manufacturing facility
View HTML
Toggle Summary Integra LifeSciences to Participate in Investor Conferences in November
PLAINSBORO, N.J., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: At 2:30 PM ET on Wednesday, November 14, 2012, Mr. Jack Henneman, Chief Financial Officer of Integra,
View HTML
Toggle Summary Integra LifeSciences Reports Third Quarter 2012 Financial Results
Raises 2012 Full-Year Earnings Guidance Hosting Investor Day Later Today PLAINSBORO, N.J., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending September 30, 2012.
View HTML
Toggle Summary Integra LifeSciences Now Offers Zero-Profile, Stand-Alone Interbody Devices for Neck and Lumbar Fixation Procedures
Expands Product Portfolio to Address Surgeon Demand for Less Surgically Invasive Options
View HTML
Toggle Summary Integra LifeSciences Launches New Integra(R) CUSA(R) NXT Bone Tip at 2012 Congress of Neurological Surgeons Annual Meeting
New Tip Expands Applications for CUSA(R) NXT Ultrasonic Tissue Ablation System
View HTML
Toggle Summary Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device
Requires Fewer Implants and Steps for ALIF Surgical Procedure
View HTML